Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells.

Authors:
Zhang LL; Lu J; Liu RQ; Hu MJ; Zhao YM and 9 more

Journal:
Acta Pharmacol Sin

Publication Year: 2020

DOI:
10.1038/s41401-020-0421-7

PMCID:
PMC7608858

PMID:
32415222

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"one replicate of raw data from ar and parental cells was deposited in the embl database under accession numbers e-mtab-5997 and e-mtab-7068.; others were deposited in the geo dataset under accession number gse142031.; raw data and processed data were deposited in the geo dataset under accession number gse142031."

Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This research was funded by the National Key Research and Development Program of China (number 2018YFC1003501), the System Biomedicine Innovation Center Program from Shanghai Jiao Tong University (number 15ZH4009), the Key Translational Medicine Program from Shanghai Jiao Tong University School of Medicine (number 15ZH1008), and the National Natural Science Foundation of China (number 81874037)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025